UBS Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$12.6M Sell
504,493
-548,451
-52% -$15.5M ﹤0.01% 3101
2025
Q4
$33.1M Buy
1,052,944
+108,399
+11% +$3.59M 0.01% 2067
2025
Q3
$33.7M Buy
944,545
+532,530
+129% +$24.3M 0.01% 2023
2025
Q2
$23.7M Buy
412,015
+200,415
+95% +$11.3M 0.01% 2194
2025
Q1
$12.3M Buy
211,600
+57,487
+37% +$3.93M ﹤0.01% 2828
2024
Q4
$12.4M Buy
154,113
+62,619
+68% +$5.35M ﹤0.01% 2824
2024
Q3
$7.33M Buy
91,494
+21,899
+31% +$1.56M ﹤0.01% 2675
2024
Q2
$4.25M Buy
69,595
+16,749
+32% +$996K ﹤0.01% 3023
2024
Q1
$2.61M Buy
52,846
+20,205
+62% +$962K ﹤0.01% 3670
2023
Q4
$1.37M Buy
32,641
+29,205
+850% +$995K ﹤0.01% 4211
2023
Q3
$113K Sell
3,436
-15,547
-82% -$530K ﹤0.01% 5756
2023
Q2
$671K Sell
18,983
-33,634
-64% -$1.11M ﹤0.01% 4565
2023
Q1
$1.49M Buy
52,617
+45,605
+650% +$1.61M ﹤0.01% 3726
2022
Q4
$291K Buy
7,012
+5,189
+285% +$223K ﹤0.01% 5155
2022
Q3
$75K Buy
1,823
+1,023
+128% +$40.8K ﹤0.01% 5972
2022
Q2
$26K Sell
800
-19,706
-96% -$717K ﹤0.01% 6559
2022
Q1
$718K Buy
20,506
+1,837
+10% +$44.2K ﹤0.01% 4416
2021
Q4
$467K Buy
18,669
+18,052
+2,926% +$668K ﹤0.01% 5036
2021
Q3
$24K Buy
+617
New +$23.7K ﹤0.01% 6975

Other funds holding PRCT